Ultra high performance liquid chromatography tandem mass spectrometry for rapid analysis of trace organic contaminants in water

Chemistry Central Journal

Volumn 7, Issue 1, 2013, Pages

  Anumol, Tarun ^a   Merel, Sylvain ^a   Clarke, Bradley O ^a,b   Snyder, Shane A ^a  

^a University of Arizona   (United States)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Glucocorticoid; Personal care product; PFC; Pharmaceutical; Solid phase extraction; Tandem mass spectrometry; Trace organic contaminant; Ultra high performance liquid chromatography; Water quality

Indexed keywords

EID: 84879034093     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-7-104     Document Type: Article

References (47)

1. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36(6):1202-1211. 10.1021/es011055j, 11944670.
2. Snyder SA, Westerhoff P, Yoon Y, Sedlak DL. Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry. Environ Eng Sci 2003, 20(5):449-469.
3. Focazio MJ, Kolpin DW, Barnes KK, Furlong ET, Meyer MT, Zaugg SD, Barber LB, Thurman ME. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States - II) Untreated drinking water sources. Sci Total Environ 2008, 402(2-3):201-216.
4. Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA. Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ Sci Technol 2009, 43(3):597-603. 10.1021/es801845a, 19244989.
5. Snyder S, Westerhoff P, Yoon Y, Vanderford B, Rexing D. Evaluation of conventional and advanced treatment processes to remove endocrine disruptors and pharmaceutically active compounds. Abstr Pap Am Chem Soc 2004, 228:184. ENVR.
6. Westerhoff P, Yoon Y, Snyder S, Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol 2005, 39(17):6649-6663. 10.1021/es0484799, 16190224.
7. Snyder SA, Wert EC, Lei H, Westerhoff P, Yoon Y. Removal of EDCs and Pharmaceuticals in Drinking and Reuse Treatment Processes 2007, Denver, CO: American Water Works Association Research Foundation.
8. Bevans HE, Goodbred SL, Miesner JF, Watkins SA, Gross TS, Denslow ND, Trenton C. Synthetic organic compounds and carp endocrinology and histology, Las Vegas Wash and Las Vegas and Callville Bays of Lake Mead Nevada, 1992 and 1995: U.S. Geological Survey Water-Resources Investigations Report 1995, 96-4266. 12 accessible at: http://pubs.er.usgs.gov/publication/wri964266.
9. Daughton CG, Ternes TA. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107:907-938. 10.1289/ehp.99107s6907, 1566206, 10592150.
10. Carlsson C, Johansson AK, Alvan G, Bergman K, Kuhler T. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. Sci Total Environ 2006, 364(1-3):67-87.
11. Snyder SA, Villeneuve DL, Snyder EM, Giesy JP. Identification and quantification of estrogen receptor agonists in wastewater effluents. Environ Sci Technol 2001, 35(18):3620-3625. 10.1021/es001254n, 11783637.
12. Stanford BD, Snyder SA, Trenholm RA, Holady JC, Vanderford BJ. Estrogenic activity of US drinking waters: a relative exposure comparison. J Am Water Work Assoc 2010, 102(11):55-65.
13. Ryu J, Yoon Y, Oh J. Occurrence of endocrine disrupting compounds and pharmaceuticals in 11 WWTPs in Seoul, Korea. KSCE J Civ Eng 2011, 15(1):57-64.
14. Chang H, Hu JY, Shao B. Occurrence of natural and synthetic glucocorticoids in sewage treatment plants and receiving river waters. Environ Sci Technol 2007, 41(10):3462-3468. 10.1021/es062746o, 17547164.
15. Herrero P, Borrull F, Pocurull E, Marce RM. Determination of glucocorticoids in sewage and river waters by ultra-high performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 2012, 1224:19-26.
16. Schriks M, van Leerdam JA, van der Linden SC, van der Burg B, van Wezel AP, de Voogt P. High-resolution mass spectrometric identification and quantification of glucocorticoid compounds in various wastewaters in the Netherlands. Environ Sci Technol 2010, 44(12):4766-4774. 10.1021/es100013x, 20507090.
17. Quinones O, Snyder SA. Occurrence of perfluoroalkyl carboxylates and sulfonates in drinking water utilities and related waters from the United States. Environ Sci Technol 2009, 43(24):9089-9095. 10.1021/es9024707, 20000497.
18. Mak YL, Taniyasu S, Yeung LWY, Lu GH, Jin L, Yang YL, Lam PKS, Kannan K, Yamashita N. Perfluorinated compounds in tap water from China and several other countries. Environ Sci Technol 2009, 43(13):4824-4829. 10.1021/es900637a, 19673271.
19. Clarke BO, Smith SR. Review of 'emerging' organic contaminants in biosolids and assessment of international research priorities for the agricultural use of biosolids. Environ Int 2011, 37(1):226-247. 10.1016/j.envint.2010.06.004, 20797791.
20. Zhang T, Wu Q, Sun HW, Zhang XZ, Yun SH, Kannan K. Perfluorinated compounds in whole blood samples from infants, children, and adults in China. Environ Sci Technol 2010, 44(11):4341-4347. 10.1021/es1002132, 20441147.
21. Contaminant Candidate List 3 http://water.epa.gov/scitech/drinkingwater/dws/ccl/ccl3.cfm.
22. Lau C, Butenhoff JL, Rogers JM. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 2004, 198(2):231-241. 10.1016/j.taap.2003.11.031, 15236955.
23. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007, 99(2):366-394. 10.1093/toxsci/kfm128, 17519394.
24. Directive 2006/122/EC of the European Parliament and of the council of 12 December 2006 http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2006:372:0032:0034:en:PDF.
25. Wilhelm M, Bergmann S, Dieter HH. Occurrence of perfluorinated compounds (PFCs) in drinking water of North Rhine-Westphalia, Germany and new approach to assess drinking water contamination by shorter-chained C4-C7 PFCs. Int J Hyg Environ Health 2010, 213(3):224-232. 10.1016/j.ijheh.2010.05.004, 20556880.
26. Hinton TG, Aizawa K. A Layperson's Primer on Multiple Stressors, Chapter 5. Multiple Stressors: A Challenge for the Future 2007, 57-69.
27. Dickenson ERV, Snyder SA, Sedlak DL, Drewes JE. Indicator compounds for assessment of wastewater effluent contributions to flow and water quality. Water Res 2011, 45(3):1199-1212. 10.1016/j.watres.2010.11.012, 21144546.
28. Ternes TA. Analytical methods for the determination of pharmaceuticals in aqueous environmental samples. Trac-Trends Anal Chem 2001, 20(8):419-434.
29. Trenholm RA, Vanderford BJ, Drewes JE, Snyder SA. Determination of household chemicals using gas chromatography and liquid chromatography with tandem mass spectrometry. J Chromatogr A 2008, 1190(1-2):253-262.
30. Stafiej A, Pyrzynska K, Regan F. Determination of anti-inflammatory drugs and estrogens in water by HPLC with UV detection. J Sep Sci 2007, 30(7):985-991. 10.1002/jssc.200600433, 17566331.
31. Morishima Y, Hirata Y, Jinno K, Fujimoto C. Solid-phase extraction device coupled to a microcolumn liquid chromatograph with a UV detector for determining estrogens in water samples. J Liq Chromatogr Relat Technol 2005, 28(20):3217-3228.
32. Zotou A, Miltiadou N. Sensitive LC determination of ciprofloxacin in pharmaceutical preparations and biological fluids with fluorescence detection. J Pharm Biomed Anal 2002, 28(3-4):559-568.
33. Zotou A, Vasiliadou C. A fluorescence-LC method for the determination of sulfonamides in biological fluids with pre-column derivatization. Chromatographia 2009, 70(3-4):389-397.
34. Lindsey ME, Meyer M, Thurman EM. Analysis of trace levels of sulfonamide and tetracycline antimicrobials, in groundwater and surface water using solid-phase extraction and liquid chromatography/mass spectrometry. Anal Chem 2001, 73(19):4640-4646. 10.1021/ac010514w, 11605842.
35. La Farre M, Ferrer I, Ginebreda A, Figueras M, Olivella L, Tirapu L, Vilanova M, Barcelo D. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J Chromatogr A 2001, 938(1-2):187-197.
36. Bossi R, Vejrup KV, Mogensen BB, Asman WAH. Analysis of polar pesticides in rainwater in Denmark by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2002, 957(1):27-36. 10.1016/S0021-9673(02)00312-6, 12102309.
37. Gros M, Petrovic M, Barcelo D. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70(4):678-690. 10.1016/j.talanta.2006.05.024, 18970827.
38. Ternes T, Bonerz M, Schmidt T. Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 2001, 938(1-2):175-185.
39. Tong L, Li P, Wang YX, Zhu KZ. Analysis of veterinary antibiotic residues in swine wastewater and environmental water samples using optimized SPE-LC/MS/MS. Chemosphere 2009, 74(8):1090-1097. 10.1016/j.chemosphere.2008.10.051, 19081124.
40. Vanderford BJ, Pearson RA, Rexing DJ, Snyder SA. Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal Chem 2003, 75(22):6265-6274. 10.1021/ac034210g, 14616010.
41. Trenholm RA, Vanderford BJ, Holady JC, Rexing DJ, Snyder SA. Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry. Chemosphere 2006, 65(11):1990-1998. 10.1016/j.chemosphere.2006.07.004, 16949633.
42. Vanderford BJ, Mawhinney DB, Trenholm RA, Zeigler-Holady JC, Snyder SA. Assessment of sample preservation techniques for pharmaceuticals, personal care products, and steroids in surface and drinking water. Anal Bioanal Chem 2011, 399(6):2227-2234. 10.1007/s00216-010-4608-5, 21225251.
43. Maldaner L, Jardim I. Determination of some organic contaminants in water samples by solid-phase extraction and liquid chromatography tandem mass spectrometry. Talanta 2012, 100:38-44.
44. Aboulfadl K, De Potter C, Prevost M, Sauve S. Time-dependent integrity during storage of natural surface water samples for the trace analysis of pharmaceutical products, feminizing hormones and pesticides. Chem Cent J 2010, 4(1):10. 10.1186/1752-153X-4-10, 2873356, 20403158.
45. Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, Solomon KR. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol Pharmacol 2004, 39(2):158-183. 10.1016/j.yrtph.2003.12.006, 15041147.
46. Boleda MR, Galceran MT, Ventura F. Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments. Environ Pollut 2011, 159(6):1584-1591. 10.1016/j.envpol.2011.02.051, 21459501.
47. Snyder SA, Adham S, Redding AM, Cannon FS, DeCarolis J, Oppenheimer J, Wert EC, Yoon Y. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 2007, 202(1-3):156-181.